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al. [4]. Recently, immunoreactive T and Tn epitope clusters Abstract PNA and VVA B4 recognize the tumor-associated T 
antigen and its immediate precursor Tn, respectively. We found have been identified in the cancer-associated mucin (MUC-1 
that both lectins are highly reactive in vitro, with human ovarian gene product) antigen, which is a unique high molecular 
carcinoma cell lines, but only VVA B4 bound significantly to weight surface glycoprotein, overexpressed in more than 
breast and oral cancer cells. This binding is inhibited by specific 90% of the human ovarian cancers and in the large majority 
monosaccharides. The lectin binding receptors were purified, of breast carcinomas types [5]. 
revealing a glycoprotein of 32 kDa for PNA, and two We have previously shown that monoclonal (rodent)and 
glycoproteins of 35 and 38 kDa for VVA B4. In vivo localization polyclonal (human) anti-T and -Tn antibodies are reactive 
of PNA was almost exclusive (except for the kidneys) to the with the human ovarian IGROV-1, OVCAR-3 and SKOV-3 
ovarian tumor xenografts. VVA B4 showed wider tissue carcinoma cells and accumulate in vivo, in ovarian carcino- 
biodistribution being preferentially accumulated in the tumors 
and ovaries, mas xenografted in nude mice [6]. In vitro, the monoclonal 
anti-T/Tn antibodies are cytotoxic to the ovarian cancer cells 
Key words: Glycoprotein receptor; Intraperitoneal therapy; in a complement-independent ma ner [6,7]. 
Lectin biodistribution; Ovarian cancer; Peanut agglutinin; The present study summarizes our recent findings on the 
Vicia villosa B4 agglutinin reactivities, both in vitro and in vivo, of the PNA and VVA 
B4 lectins with human ovarian carcinoma cell lines. We have 
identified the PNA and VVA B4 binding receptors by affinity 
chromatography on lectin agarose-linked columns, and dem- 
1. Introduction onstrated that both lectins accumulated in ovarian tumors 
xenografted in nude mice. The lectin tumor localization in 
Many of the tumor-associated antigens have been identified vivo is associated with a rapid blood clearance of both lectins, 
as carbohydrate-containing structures, expressed in the form yet being associated with a tumor suppressive effect, in the 
of either glycoproteins or glycolipids on the tumor cell surface case of PNA. 
[1]. These structures may be the result of: (a) the accumula- 
tion of incomplete glycosylated precursor chains (because of a 2. Materials and methods 
decreased activity of synthesizing enzymes); (b) the produc- 
tion of new oligosaccharides (due to increased aberrant gly- 2.1. Media 
cosylation of carbohydrate chains); (c) changes in the density RPMI 1640 and Dulbecco's modified Eagle's media (DMEM) were 
purchased from Gibco (Grand Island, NY). All additional tissue cul- 
of the carbohydrate units on the cell surface; and/or (d) ex- ture products were from BioLab (Jerusalem). Culture media were 
posure of cryptic sugar chains usually covered by other strut- supplemented with 10% heat-inactivated fetal calf serum (FCS), 
tures. In many cases, the changes in the carbohydrate expres- 2 mM c-glutamine, non-essential amino acids (as recommended by
sion was found to play a key role in determining the the supplier), 50 units/ml penicillin, 50 ~tg/ml streptomycin and 
125 p~g/ml Fungizone. metastatic behavior of the tumor cells [2]. Among those spe- 
cific carbohydrate structures are the Thomsen-Friedenreich 2.2. Animals 
(T) and Tn antigens, whose epitopes are Gal[31,3,Gal- Athymic CD1 female nude mice (6-8 weeks old) were obtained 
NAcotO-Ser/Thr and GalNAc~O-Ser/Thr respectively, which from the Animal Breeding Center of the Weizmann Institute of 
have been identified in more than 90% of the cancers of the Science. 
adenocarcinoma types, including those of the breast and the 
2.3. Cell lines and lectins 
ovaries [3]. These carbohydrate-associated tumor antigens are All cell lines used in this study originated from the American Type 
recognized by the lectins of Araehis hypogaea (peanut; PNA) Culture Collection (Rockville, MD, USA), except for IGROV-1 which 
and Vicia villosa B4 (VVA B4), which react with the T and Tn was kindly provided by Prof. Z. Eshhar from our Department, and 
antigens, respectively [4]. Both lectins, however, may interact FS-11- which was kindly provided by Prof. M. Revel from the De- 
with other closely related structures, as described by Chert et partment of Molecular Genetics and Virology. 
All the lectins, in either native or immobilized (agarose-linked) 
form, were purchased from Sigma (St. Louis, MO, USA). 
*Corresponding author. Fax: (972) (8) 9469712. 2.4. Tumor cell growth in vitro 
All the cancer cell lines were grown in RPMI 1640 culture medium 
Abbreviations." Gal, D-galactose; GalNAc, N-acetyl-D-galactosamine; and maintained at37°C in a 5% CO2 humidified atmosphere, until cell 
Glc, D-glucose; I.D., injection dose; PNA, peanut (Arachis hypogaea) confluence. C ll suspensions were prepared by a brief incubation in 
agglutinin; T/B, tissue to blood ratio; VVA B4, Vie& villosa B4 the presence of trypsin/EDTA (0.25%/0.02%). The cells were washed 
agglutinin thrice in RPMI medium, harvested (800×g, 5 min) and resuspended 
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to a concentration of 2 X 105 cells per ml of the culture medium. FS- 11 D-glucopyranoside, 5 mM EDTA and 0.01% sodium azide) to a con- 
cells were maintained in DMEM plain medium, as described above, centration of 2.5 mg protein per ml. 
2.5. Tumor cell transfer in athymie nude mice 2.8. Purification of the lectin binding glyeoproteins from the human 
The IGROV-I tumor cells were cultured and harvested as above, ovarian (IGROV-1) cancer cell membranes 
and then injected (3 x l06 cells per mouse) subcutaneously (s.c.) into The PNA-reactive glycoproteins were isolated from the tumor cell 
the animals. The OVCAR-3 cells were maintained in vivo, by serial membranes, by a single step affinity chromatography on PNA-agar- 
transfer i.p. of the tumor cells (6 x 106 cells per mouse) into the ani- ose-linked column. The specific adsorbed glycoproteins were eluted 
mals. The developed ascitic OVCAR-3 tumor cells grow in large clus- with Gal 0.3 M, as described in the text. VVA B4-reactive glycopro- 
ters making the cell count difficult, therefore the mean cell number in teins were similarly isolated by affinity chromatography on a VVA 
one cluster was estimated to be 15. B4-agarose linked column, using GalNAc 0.15 M as the eluting sugar. 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS- 
2.6. Direct [12Sl]lectin binding and competitive radioimmunoassay PAGE) was performed on a 12.5% linear gradient separating el 
(RIA) and a 5°/,, stacking gel, using the silver staining method, for protein 
Cell monolayers were prepared in 24-well plates (Nunc, Denmark) detection [9]. 
by plating 1 x 10 ~ trypsinized cells in 0.5 ml of the appropriate culture 
medium, followed by overnight incubation at 37°C in a 5% CO~ 2.9. Cell viabi#ty assay 
humidified atmosphere, to allow cell adherence. The obtained adher- Cell survival was assessed by the 3-(4,5-dimethylthiazol-2-yl)-2,5- 
ent cell monolayers were washed twice with PBS and incubated for 2 h diphenyl tetrazolium bromide (MTT, from Sigma) staining assay, 
at room temperature (~25°C) with various concentrations of the which is based on MTT reduction into formazan by viable cells 
iodine 125I-radiolabeled (using the chloramine T method, [8]) lectins [10]. Briefly, tumor cells were plated (1 x 104 cells in 0.1 ml RPMI 
suspended in 300/al of PBS containing 1% BSA. The cells were then culture medium per well) in a 96-well microtiter plate. After overnight 
washed thrice with PBS, solubilized in 1 ml of 0.5 N NaOH, and the incubation at 37°C in 5% CO2 humidified atmosphere, the cells were 
overall radioactivity was monitored in a Gamma counter (Riastar, treated with the lectins, at the concentrations and incubation period 
Packard Inc., IL). indicated in the text. At the end of incubation, the culture medium 
Competitive radioimmunoassay experiments with the free monosac- was removed from the wells and replaced with 100 p~l of MTT solu- 
charides (D-galactose, Gal; N-acetyl-D-galactosamine, GalNAc; and tion (0.5 mg/ml of the culture medium). After 3 h incubation at 37°C, 
D-glucose, Glc; all from Sigma), were performed by preincubation 150 ~1 of 0.04 N HCI in isopropanol were added to each well, to 
of the radiolabeled lectins with or without sugars for one hour at dissolve the insoluble formazan-containing crystals formed within 
room temperature, before their addition to the tumor cells for an the viable cells. Optical density was determined at 540 nm wavelength, 
additional 1 h at room temperature. The cells were washed twice in using an automatic ELISA reader (Titertek, Multiskan MCC/340 
PBS and the radioactivity levels were monitored in a Gamma counter. MKII, Labsystems, Finland). 
2. 7. Isolation of human ovarian IGROV-1 cancer cell membranes 2.10. In vivo distribution of the radiolabeled lectins in ovarian 
The cell membrane preparations were prepared from IGROV-1 tumor-bearing mice 
tumor cells grown (as described above) at logarithmic phase in plastic The biodistribution of the 1251-radiolabeled lectins was determined 
tissue culture flasks (Nunc, Denmark). The obtained cell monolayers in nude mice bearing either solid subcutaneous (IGROV-1) or intra- 
(about 5 x 107 cells) were washed twice in ice-cold PBS and once in peritoneal ascitic (OVCAR-3) tumor xenografts. The mice were in- 
Buffer A solution (containing potassium phosphate buffer 0.01 M, pH jected with the lectins (for IGROV-1, when the tumors reached 0.5- 
7.4; phenylmethylsulfonyl fluoride 0.5 mM and tosyllysinechloro- 1.2 cm 3 volume size; and for OVCAR-3, 20 days after the tumor 
methyl ketone 1 raM; all from Sigma). After cell dispersion with inoculation), and 16 h post-injection, tissue samples were removed, 
the aid of a sterile rubber policeman, the cells were disrupted by weighed and their radioactivity measured in a Gamma counter. The 
freeze-thawing (twice) at -80°C (for 24 h) and subsequent homoge- biodistribution data are expressed as percentage of the injected dose 
nization (10-15 strokes on ice) in a loose-fitting Dounce glass homog- (% I.D.) per gram wet tissue. 
enizer. After centrifugation at 1500xg for 15 min, the pellet (contain- 
ing nuclei and cell debris) was discarded, and the supernatant 2.11. Effects of PNA on ovarian OVCAR-3 cancer cells xenograftedin 
centrifuged at 200000Xg (Beckman rotor SW28) for 16 h. The ob- nude mice 
tained pellet was washed in 10 ml of buffer A, centrifuged again at The ovarian OVCAR-3 tumor cells were prepared as described 
200000Xgfor4handdissolved( inPBScontain ing25mMn-octy l -~l -  above, suspended to a concentration of 2.5×106 cells in 0.5 ml 
Table 1 
Biodistribution of [125I]PNA and [125I]WA B4 in CD1 athymic female nude mice, xenografted with either solid subcutaneous) IGROV-I or 
ascitic (intra-abdominal) OVCAR-3 human ovarian tumors 
Tissue PNA ~ VVA B4 ~ 
% I.D. _+ S.D. b T/B ° % I.D. + S.D. b T/B c 
Lung 0.35 _+ 0.09 1.17 2.76 + 1.68 15.33 
Heart 0.22 + 0.08 0.73 0.71 _+ 0.42 3.94 
Liver 0.48 + 0.31 1.60 2.84 _+ 1.37 15.78 
Spleen 0.35 _+ 0.17 1.17 3.52 + 2.10 19.55 
Kidney 3.04+ 2.59 10.13 5.27 _+ 1.38 29.28 
Skin 0.36 _+ 0.03 1.20 0.78 + 1.25 4.33 
Intestine 0.38 -+ 0.12 1.27 3.86 + 1.92 21.44 
Ovaries 0.50 _+ 0.43 1.67 13.89 + 5.11 77.17 
Muscle 0.19 + 0.07 0.63 0.34 _+ 0.22 1.89 
Turn o r: 
solid (IGROV- 1) 1.85 _+ 1.48 6.17 0.66 + 0.45 3.67 
ascitic (OVCAR-3) 6.99 + 0.09 23.30 10.81 + 0.51 60.05 
Blood 0.30 _+ 0.06 1.00 0.18 + 0.09 1.00 
~The lectins were administered (i.p.) at a dose of 2.6x 106 cpm/0.5 ktg protein for PNA, and 2.1 x 106 cpm/3 lag protein for VVA B4, to the tumor- 
bearing mice. At 16 h post-injection, tissue samples were removed and their radioactivity measured. 
bThe results express the percentage of the injected lectin dose (% I.D.) per gram of tissue and represent mean + S.D. values from 4-5 animals. 
CTissue to blood ratio. 
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RPMI medium, and then injected (i.p.) to the nude mice (each experi- 1 2 3 
mental group consisted of at least 5 animals). The mice were treated 
(i.p.) with the lectin, at the doses and time schedules indicated in the 
text, and the tumor growth was monitored by recording the weight ]~Da 
changes of mice. 
3.  Resu l ts  
60- - -  3.1. Binding of the lectins to human tumor cells, in vitro 
The binding of PNA and VVA B4 lectins to the tumor cells 50  
in vitro, was tested by a direct radioimmunoassay, using io- 
dine-labeled (125I) radioactive l ctins (Fig. 1). Both PNA and 40  " - - "  
VVA B4 (2 and 5 gg/ml respectively) were found to be highly 
reactive with the ovarian carcinoma cells tested, revealing 
about 4.7, 2.7 and 2.4x 106 PNA-binding sites (taking PNA 
Mr as 120 kDa) per cell for IGROV-1, OVCAR-3 and SKOV- 30  
3 cancer cell lines, respectively. The approximate number of 
binding sites per cell for VVA B4 (taking its Mr as 143 kDa) 
was even higher: 7.0, 5.5 and 2.5 × 106, respectively. Normal 
FS-11 fibroblastic ells used as controls, were non-reactive. 
VVA B4 was also highly reactive with the KB epidermoid 
(about 7.4×106 binding sites per cell) and breast SKBr-3 ~)0  '~  
(about 4× 106 binding sites per cell) carcinoma cells. PNA 
Fig. 2. SDS-polyacrylamide gelelectrophoresis of the affinity chro- 
matography purified PNA (lane 2) and VVA B4 (lane 3) reactive 
PNA glycoproteins, i olated from the ovarian IGROV-1 cancer cell mem- 
branes. Lane 1 represents he 10 kDa protein ladder molecular 
weight standard markers from Gibco. 
in contrast, exhibited only a weak reactivity (about 3.83-fold 
~-  higher as compared to that obtained with the FS-11 cells) with 
,->. the human SKBr-3 cancer cells (Fig. 1), and did not bind at 
_ all to the KB epidermoid cancer cells. 
looooo- 
+1 3.2. Inhibition of the lectin binding to the tumor cells by free 
monosaccharides e~ 
r,.) ~oo- The binding of both PNA (610 000 + 35 000 cpm at 2 gg/ml) 
Z and VVA B4 (100568+ 19344 cpm at 4 I.tg/ml) lectins to the < 
~ IGROV-1 cancer cells was significantly (P < 0.005; Student's 
o- - " ~ t-test) inhibited by the addition of Gal (25 mM). This sugar IGROV- IOVCAR-3 SKOV*3 SKBt*-3 KB F$-I1 
rD led to decrease of the PNA binding by 62% (231 800 + 18 544 
Z ~25~ cpm) and that of VVA B4 by 49% (50853+3156 cpm). Gal- 
B WAI34 NAc, which is regarded as the haptenic immunodominant 
Z carbohydrate of Tn antigen, indeed inhibited the VVA B4 
~o~oo- binding to IGROV-1 cells by 59% (41 452 + 10 902 cpm), but 
Z caused only 16% (512 400 + 37 405 cpm) reduction of the PNA 
¢,.) binding. The irrelevant non-haptenic Glc sugar led to only a 
75~o -
-1 slight inhibition (16-18%) of either lectins. 
3.3. Isolation of the lectin-reactive glycoproteins from human 
50000- 
ovarian tumor cells 
The PNA-reactive glycoproteins were isolated from the tu- 
~ .  mor cell membranes by affinity chromatography on a PNA- 
agarose linked column. Essentially, 2 ml (5 mg protein) of the 
i ~ crude cell membrane material was applied to the column 
o- . ~ (0.5x3.5 cm) equilibrated with PBS 0.01 M; pH 8. After 
mRov.lovc, x.asxovo sx.,.3 xB  vs-,t washing with the same buffer, the specific adsorbed glycopro- 
CELL TYPE teins were eluted with Gal 0.3 M, and submitted to extensive 
dialysis against PBS 0.01 M; pH 7.2. The protein content was 
Fig. 1. Binding of [125I]PNA (A) and VVA B4 (B) (added at 2 and 
estimated by absorbance at 280 nm, and the samples were 5 gg/ml, respectively) to human ovarian (IGROV-1, OVCAR-3 and 
SKOV-3), breast (SKBr-3) and oral epidermoid (KB) cancer cells, lyophilized to one tenth of the original volume. 
cultured (1 × 105 per well) in vitro. The VVA B4-reactive glycoproteins were similarly isolated 
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A ~ (subcutaneous) or ascitic OVCAR-3 (intra-abdominal) tumor 
Z ~0 ~ r  ] ~ xenografts (Table 1). The tissue distribution was measured 16 
,,- h post-injection and calculated as % I.D. per gram tissue. The 
tissue to blood (T/B) ratio, which is an important factor in 
~ tumor radioimaging and historadiographic studies, was also 
tO  :~.  
calculated. As shown in Table 1, when [a25I]PNA was injected 
~- :°- i.p. to the tumor-bearing mice, it did accumulate at relatively 
=c ~. high levels in the ascitic OVCAR-3 (T/B =23.30) and solid 
IGROV-1 (T/B = 6.17) tumor xenografts. It did not show ac- 
l 0  , , i J , J , J , J 
. . . .  ~ . . . . . . . . . . . . . .  cumulation in other organs, except for the kidneys (T/ 
DAYS AFTER TUMOR INOCULATION B= 10.13). This lectin accumulation i  the kidneys is due to 
Fig. 3. Effects of PNA (panel A; rn) and VVA B4 (panel B; zx) natural clearance of the lectin from the plasma, as previously 
treatment (2 i.p. injections of 200 lag each, administered 3 days shown by others [ll]. The biodistribution of [125I]VVA B4 
apart) on the development of human ovarian (OVCAR-3) cancer lectin (injected i.p.) revealed a remarkable lectin uptake in 
cells intraperitoneally xenografted (2.5;4 l06 cells per mouse) in fe- 
male CD1 nude mice. The ascites tumor cell development was moni- the ovaries (T/B = 77.17) and in the ascitic OVCAR-3 tumors 
tored by recording the changes in the total weight (g + S.D.) in the (T/B = 60.05). This lectin, however, showed significant accu- 
animals. The open circles depict the cell growth in the untreated mulation in almost all the organs tested, except for the muscle 
group of mice. tissue. 
Both [125I]PNA and VVA B4 were effectively cleared from 
by application of 1.2 ml (3 mg protein) of the crude cell the blood, giving average % I.D. g 1 of 0.30 (+0.06)for PNA, 
membrane material to a VVA B4-agarose linked column and 0.18 (+0.09)for VVA B4 (Table 1). 
equilibrated with PBS 0.01 M; pH 7.2. After washing of the 
column with the same buffer, the specific adsorbed glycopro- 3.6. Effect of the lectin injection on the ovarian cancer cells 
teins were eluted with GalNAc 0.15 M, pooled, dialyzed xenografted in nude mice 
against PBS and lyophilized to one fifth of the original vol- The effect of the PNA injection on human ovarian OV- 
ume. CAR-3 cells, grown i.p. in female nude mice is depicted in 
SDS-PAGE of the purified lectin-reactive glycoproteins re- Fig. 3. Injection (i.p.) of this lectin (2 doses of 200 tag each, 
vealed the presence of one major band migrating to a relative given 3 days apart, starting at 4 days after the tumor inocula- 
molecular weight (Mr) of 32 kDa for PNA, and at least two tion) to the tumor-bearing mice, was associated with a slight, 
bands with Mr of 35 and 58 kDa respectively, for VVA B4 but statistically significant (P < 0.05; Student's t-test) suppres- 
(Fig. 2). sion of the tumor development in the mice. This tumor 
growth inhibitory effect (which was not observed with VVA 
3.4. Viability of human ovarian carcinoma cells cultured in the B4) was accompanied by an increase in the mean survival time 
presence of the lectins (MST) of the mice, from 28.25 + 6.04 days for the untreated 
The effects of PNA and VVA B4 (native forms) on the cell group to 36.70 + 8.10 days in the lectin-treated one (P < 0.05). 
viability of human ovarian IGROV-1 cancer cells cultured in 
vitro was performed by the method described by Mosmann 4. Discussion 
[10]. Essentially, the cells were seeded at 10000 cells per well, 
and treated 24 h later with various doses (2-100 gg/ml) of the T antigen and its immediate precursor Tn, are oncofetal 
lectins, for an additional incubation period of 72 h. The cell antigens overexpressed in many epithelial malignancies, in- 
viability was evaluated by the MTT ('tetrazolium') staining cluding ovarian, breast and other adenocarcinomas [3]. A 
assay, which is based on MTT reduction into formazan by wide variety of lectins have been identified that recognize 
the viable cells with functional mitochondrial dehydrogenases, these epitopes with high binding affinities and minimal bind- 
Neither PNA nor VVA B4 (up to 100 gg/ml) did exert any ing to normal tissues. In the present study we investigated 
significant inhibitory/stimulatory effect on the growth of the both the in vitro and in vivo reactivities of PNA (which rec- 
tumor (IGROV-1) cells, cultured for up to 72 h in vitro (data ognizes the Gall31,3 GalNAc-O-Ser/Thr motif of T antigen), 
not shown). In contrast, the same IGROV-1 cancer cells were and VVA B4 (which is reactive with the GalNAc-O-Ser/Thr 
highly sensitive to the toxic effect of another Gal/GalNAc- structure of Tn antigen) on human ovarian carcinoma cell 
binding lectin from Ricinus communis (RCA 60, also referred lines. Both lectins, however, are not strictly specific for T 
to as ricin). This lectin (which belongs to the ribosome-inacti- and Tn and may recognize other closely related structures [4]. 
vating protein [RIP] family) induced a 80% (+ 2) suppression Our results demonstrate hat both PNA and VVA B4 lec- 
(P < 0.0005) of the ovarian tumor cell growth (observed after tins are highly reactive with the human ovarian IGROV-1, 
a 16 h incubation period) at lectin concentration as low as 0.1 OVCAR-3 and SKOV-3 cancer cell lines, detecting about 
p,M, which corresponds to 0.6 gg/ml lectin concentration, tak- 2.4-7.0 × 106 lectin binding sites per cell in these carcinoma 
ing the ricin molecular weight as 60 kDa. cells. These values are very close to those previously reported 
by others for the binding of PNA to poorly differentiated 
3.5. Biodistribution of the radiolabeled PNA and VVA B4 hepatoma cells [12]. Similarly high levels of lectin binding sites 
lectins in athymic nude mice bearing human ovarian were also observed for VVA B4 in human breast SKBr-3 and 
tumor xenografis oral KB carcinoma cells (Fig. 1B). In contrast however, the 
The radiolabeled [125I]PNA (2.6x 106 cprrd0.5 gg protein) PNA binding to SKBr-3 carcinoma was relatively low, and no 
and VVA B4 (2.1 × 106 cpm/3 gg protein) lectins were admi- PNA binding could be detected in KB carcinoma cells (Fig. 
nistered (i.p.) to the nude mice bearing either solid IGROV-1 1A). The weak or absence of responsiveness of these cell lines 
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with PNA does not correlate our previous results using im- ward human ovarian and breast cancer cells grown in cul- 
munochemical methods, which demonstrated that both poly- tures, but not toward human normal breast cells ([6], Aviche- 
clonal and monoclonal anti-T antibodies are highly reactive zer et al., in preparation). Moreover, we have recently shown 
with these cancer cells [6,7]. It is possible therefore, that the that a bacterial lectin (PA-I of Pseudomonas aeruginosa) which 
lectins and antibodies recognize different molecular structures like PNA and VVA B4 is a Gal/GalNAc binding lectin, but in 
anchored on the tumor cell surface. Another possibility is that contrast o them interact preferentially with B, pk, P1 and I 
the type (e.g. ~Jl] anomeric forms), number ('clustering') and/ (rather than T and Tn) blood group antigens, is highly cyto- 
or location of the Gall31,3 GalNAc structural units along the toxic to human ovarian and oral cancer cells cultured in vitro 
T antigen backbone, are critical for the PNA lectin binding, [20]. Its toxicity however, was much lower than that of ricin 
but do not play an important role in binding to antibodies, which is toxic to these cells in the ng dose range. Ricin is a 
The specificities of the interactions of the PNA and VVA protein composed of two different polypeptide chains A and B 
B4 lectins with the tumor cells, was demonstrated by inhibi- (the lectin subunit) linked by a single disulfide bridge. It exerts 
tion tests using free monosaccharides. In the case of PNA, its toxic activity (towards a wide variety of both transformed 
Gal was the most potent inhibitor while GalNAc and Glc and non-transformed cells), through the A chain unit which is 
induced only a feeble inhibitory effect. In contrast, VVA B4 capable of inactivating eukaryotic ribosomal RNA leading to 
binding to the same tumor cells was inhibited by both Gal- inhibition of the tumor cell protein synthesis [21]. All these 
NAc and Gal, but not by Glc, used as an irrelevant sugar, results taken together suggest, therefore, that the mechanism 
Isolation and characterization f the PNA and VVA B4 of tumor cell suppression, induced by either the antibodies or 
binding receptors from the IGROV-1 carcinoma cells was lectins, is unlikely to be simply due to recognition of Gall 
performed by affinity chromatography on appropriate immo- GalNAc terminal residues, but represents a much more com- 
bilized (agarose-linked) lectins, revealing a band of 32 kDa as plex profile of ligand-tumor cell interactions through specific 
the major PNA-specific glycoprotein receptor, and at least cancer-associated carbohydrate antigens. In some cases, these 
two bands of 35 and 58 kDa respectively, as specific glyco- interactions may represent the first step in the triggering of the 
protein receptors for VVA B4 (Fig. 2). None of these glyco- cascade vents involved in the programmed cell death. 
proteins reacted (in Western immunoblotting) with the poly- We have examined the potential of PNA and VVA B4 (125I- 
clonal anti-T and anti-Tn antibodies (unpublished results), labeled) for tumor localization studies in a mouse xenograft 
although both T and Tn antigenic receptors were previously model. PNA was shown to have a high degree of selective 
detected in this human cancer cell line by both direct (e.g. reactivity for human ovarian tumors xenografted in nude 
radioimmunoassay) and indirect (e.g. immunoperoxidase mice, as compared to the other organs examined, except for 
staining and FACS analysis) immunochemical methods [6,7]. the kidneys which also accumulated significant levels of the 
These results suggest herefore, that in addition to the immu- radioactive lectin (Table 1). This lectin accumulation i  the 
noreactive T and Tn antigens, PNA and VVA B4 react with kidneys is due to natural clearance of the lectin from the 
other glycoprotein or glycolipid structures anchored on the plasma, as previously described [11,22]. VVA B4 was also 
cell surface of the ovarian IGROV-1 cells, although the pre- found to accumulate in the ovarian tumor xenografts, even 
cise nature of these binding receptors i unknown. Such PNA- at higher levels than PNA, as judged by the remarkable le- 
binding receptors with closely similar molecular weight vated tissue to blood (T/B) ratios (Table 1). This lectin how- 
(around 30 kDa) were described in human urinary bladder ever, showed a wide tissue binding distribution reflected by 
carcinomas [13] and in the rat tumor BSp73 cell lines [14] .  relatively high levels of radioactivity uptake in almost all the 
PNA-binding receptors with relatively high molecular weights tissues tested. Since the expression of Tn and other related 
(more than 110 kDa) were also reported, for example in hu- (e.g. sialyl Tn) antigens recognized by this lectin is very lim- 
man gastric carcinoma cells and in the plasma membranes of ited (because they are masked by additional sugar residues) in 
rat hepatoma cells [12,15,16]. normal tissues and secretions, we presume that the observed 
Since some of the 'anti-T/Tn'-like l ctins are toxic to certain interactions of VVA B4 with the normal tissues is due to 
cell lines that bear the appropriate recognition epitopes cross-reactivity with non-specific cross-reacting antigens. Sup- 
[17,18], and others have growth-stimulatory effects on certain port to this assumption came from our recent observation on 
gastrointestinal cell lines and tissue explants [19], we have the in vivo accumulation i  the tumor of specific polyclonal 
performed both in vivo and in vitro experiments o determine and monoclonal anti-Tn antibodies (12~I-labeled), which was 
whether the binding of PNA and VVA B4 to the human not associated with such a pronounced accumulation i  the 
ovarian cancer cells, is associated with such inhibitory/stimu- normal tissues (except for the kidneys) as that observed here 
latory effects. Neither PNA nor VVA B4 lectins (examined at with VVA B4. 
doses of 2-100 lag/ml) exhibited any stimulatory or inhibitory The results of the present study demonstrate herefore, the 
effect on the growth of the ovarian (IGROV-1) cancer cells, differential reactivities (both in vitro and in vivo) of PNA and 
grown at up to 3 days in cultures. The injection of PNA (2 VVA B4 with human carcinoma cells. Of particular impor- 
doses of 200 ~tg each, administered i.p., 3 days apart) to the tance are the results obtained with PNA. This lectin localized 
tumor-bearing mice, was even associated with a limited sup- remarkably in human ovarian tumor cells cultured in vitro, 
pressive rather than stimulatory effect (Fig. 3) on the tumor and exhibited a selective targeting to the ovarian tumors xe- 
cell growth, nografted in nude mice. The lectin injection was associated 
These results are not in accordance with our recent data on with a rapid clearance from the body, yet being associated 
the effects of specific anti-T and anti-Tn monoclonal antibod- with a certain suppressive ffect on the tumor cell growth. 
ies on human tumor cells grown in vitro. According to those All these properties taken together indicate therefore, that 
data, both anti-T and anti-Tn monoclonal antibodies exert this lectin is a potentially good candidate molecule for deliv- 
cytotoxic effects (in a complement-independent manner) to- cry of drugs, radionuclides and toxins for the treatment of 
108 D. Avichezer, R. Arnon/FEBS Letters 395 (1996) 103-108 
ovarian cancer, more particularly for therapy of the residual [8] Hunter, M.W. and Greenwood, F. (1962) Nature 194, 495-496. 
Laemmli, U.K. (1970) Nature 227, 680-685. 
malignant peritoneal (including ascitic) disease, which remains [~] Mosmann, T. (1983) J. Immunol. Methods 65, 55-63. 
the major problem in post-operative patients. Yet, due to [11] Boniface, G.R., Suresh, M.R., Willans, D.J., Tam, Y.K., Shysh, 
species-specific differences in tissue glycosylation, the immu- A., Longenecker, B.M. and Noujaim, A.A. (1986) J. Nucl. Med. 
nogenicity and pharmacokinetic properties of both PNA and 27, 668 676. 
VVA B4 lectins in tumor-bearing patients need to be more [12] Goulut°Chassaing, C., Decastel, M., Tran, A.T., Tabary, F. and 
Bourrillon, R. (1992) Biochimie 74, 101-108. 
extensively investigated. [13] Langkilde, N.C., Wolf, H., Clausen, H. and Orntoft, T.F. (1992) 
Cancer Res. 52, 5030-5036. 
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